Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prognostic Role of the Systemic Immune–Inflammation Index in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy: Results From a Large Multicenter International Collaboration Publisher Pubmed



Mori K1, 2 ; Resch I1 ; Miura N1, 3 ; Laukhtina E1, 4 ; Schuettfort VM1, 5 ; Pradere B1, 6 ; Katayama S1, 7 ; Dandrea D1 ; Kardoust Parizi M1, 8 ; Abufaraj M1, 9 ; Fukuokaya W2 ; Colla Ruvolo C10, 11 ; Luzzago S10, 12 ; Knipper S10, 13 Show All Authors
Authors
  1. Mori K1, 2
  2. Resch I1
  3. Miura N1, 3
  4. Laukhtina E1, 4
  5. Schuettfort VM1, 5
  6. Pradere B1, 6
  7. Katayama S1, 7
  8. Dandrea D1
  9. Kardoust Parizi M1, 8
  10. Abufaraj M1, 9
  11. Fukuokaya W2
  12. Colla Ruvolo C10, 11
  13. Luzzago S10, 12
  14. Knipper S10, 13
  15. Palumbo C10, 14
  16. Karakiewicz PI10
  17. Briganti A15
  18. Enikeev DV4
  19. Roupret M16
  20. Margulis V17
  21. Egawa S2
  22. Shariat SF1, 4, 9, 17, 18, 19, 20, 21
Show Affiliations
Authors Affiliations
  1. 1. Department of Urology, Medical University of Vienna, Wahringer Gurtel 18-20, 1090, Vienna, Austria
  2. 2. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
  3. 3. Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan
  4. 4. Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russian Federation
  5. 5. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  6. 6. Department of Urology, CHRU Tours, Universite Francois Rabelais de Tours, PRES Centre Val de Loire, Tours, France
  7. 7. Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
  8. 8. Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Research Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan
  10. 10. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada
  11. 11. Department of Urology, University of Naples Federico II, Naples, Italy
  12. 12. Department of Urology, IRCCS, European Institute of Oncology, Milan, Italy
  13. 13. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  14. 14. Department of Medical and Surgical Specialties, Radiological Science, and Public Health, Urology Unit, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy
  15. 15. Department of Urology, Vita Salute San Raffaele University, Milan, Italy
  16. 16. Urology department, Sorbonne Universite, ONCOTYPE-URO, AP-HP, Hopital Pitie-Salpetriere, GRC n°5, Paris, 75013, France
  17. 17. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, United States
  18. 18. Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
  19. 19. Department of Urology, Weill Cornell Medical College, New York, NY, United States
  20. 20. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria
  21. 21. European Association of Urology Research Foundation, Arnhem, Netherlands

Source: Cancer Immunology# Immunotherapy Published:2021


Abstract

Purpose: To investigate the prognostic role of the preoperative systemic immune–inflammation index (SII) in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU). Materials and methods: We retrospectively analyzed our multi-institutional database to identify 2492 patients. SII was calculated as platelet count × neutrophil/lymphocyte count and evaluated at a cutoff of 485. Logistic regression analyses were performed to investigate the association of SII with muscle-invasive and non-organ-confined (NOC) disease. Cox regression analyses were performed to investigate the association of SII with recurrence-free, cancer-specific, and overall survival (RFS/CSS/OS). Results: Overall, 986 (41.6%) patients had an SII > 485. On univariable logistic regression analyses, SII > 485 was associated with a higher risk of muscle-invasive (P = 0.004) and NOC (P = 0.03) disease at RNU. On multivariable logistic regression, SII remained independently associated with muscle-invasive disease (P = 0.01). On univariable Cox regression analyses, SII > 485 was associated with shorter RFS (P = 0.002), CSS (P = 0.002) and OS (P = 0.004). On multivariable Cox regression analyses SII remained independently associated with survival outcomes (all P < 0.05). Addition of SII to the multivariable models improved their discrimination of the models for predicting muscle-invasive disease (P = 0.02). However, all area under the curve and C-indexes increased by < 0.02 and it did not improve net benefit on decision curve analysis. Conclusions: Preoperative altered SII is significantly associated with higher pathologic stages and worse survival outcomes in patients treated with RNU for UTUC. However, the SII appears to have relatively limited incremental additive value in clinical use. Further study of SII in prognosticating UTUC is warranted before routine use in clinical algorithms. © 2021, The Author(s).
Other Related Docs
11. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
17. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)